About the 15th World ADC London 2025

Europe’s Longest Standing, Most Comprehensive & Definitive ADC Forum

As ADCs progress to become the modality of choice reshaping the face of oncology care, the 15th World ADC London returns as the first major industry-leading conference for the ADC community in the year. Uniting 700+ of your peers across 4 days of unparalleled learning, this is your chance to bring more ADCs to a wider patient population faster.

Whether you are a novice to the ADC field or a long-standing expert, you can expect to gain a comprehensive overview of the emerging trends taking hold of the field and access focused networking opportunities with established pharma (Daiichi Sankyo, AstraZeneca, GlaxoSmithKline), innovating biotechs (ADC Therapeutics, OBI Pharma, Zymeworks), and industry-leading solution providers.

With tailored content for anyone working in ADC development, you’ll discover innovations in topoisomerase I and novel non-cytotoxic payloads and progress your asset successfully through preclinical and clinical development. You’ll also learn to select the combination partner smartly, establish manufacturing processes under accelerated timeframes, and navigate global supply chain challenges.

Built with the industry’s specific needs in mind, next year’s agenda has end-to-end ADC content for all your team including:

World ADC London - Content Tracks
FULL EVENT GUIDE
REGISTER

More than Just a Meeting

As the ADC community reunites under one roof to learn, collaborate, and celebrate the frenzied success and growth of the field, make sure to take part and enjoy the variety of structured networking opportunities beyond the scientific presentations, including:

Drinks
Receptions

Poster
Sessions

Tech
Slam

Breakfast Briefings

Networking Dinners

Industry Awards

Plan Your 4-day World ADC London Experience

Seminar Day –
Monday, 3rd March

Spanning innovation and strategy across novel conjugates, toxicity, combination therapies, and regulatory CMC, the seminar day is designed to showcase the areas of the most important ADC bottlenecks and areas of innovation led by forward-thinking ADC experts.


NEW: ADC Licensing, Partnering & Investment Session

This is your chance to understand what innovation, data, and risk-taking criteria are fuelling ADC investment and collaboration. Hear from key stakeholders from BioNTech, Innovent Biologics, Ipsen, Johnson & Johnson, Multitude Therapeutics, Oxford BioTherapeutics, and Zymeworks ahead of informal networking to foster new relationships for ADC partnerships and investment ahead of the main conference days.

Introduction to ADCs Day

Tailored for new members of the ADC community, join this ADC 101 day to establish a core understanding of the essential elements in ADC discovery and early development.

3rd Novel Conjugates Day

Ride the wave of ADC design innovation with sessions showcasing Degrader-Antibody Conjugates, bispecific ADC design, dual payload and high DAR ADCs, and bioconjugate applications in neurological diseases.

2nd Toxicity Day

Learn from the best to tackle ADC’s top translational bottleneck through identifying on and off-target toxicity mechanisms, leveraging in vitro and in vivo model predictivity, and understanding toxicity profiles of ADC with novel linker payloads and targets.

3rd ADCs in Combination Day

Smartly select the right ADC combination partner across breakdowns of clinical stage ADC-immunotherapy performance, understanding preclinical rationale and mechanism determination, and exploring ADCs in sequence to counter resistance mechanisms.

NEW: 1st Regulatory CMC Day

Tackling the necessity to understand ADC regulatory data submissions and attitudes, attend to tackle ADC modality-specific challenges, streamline impurity control strategy, and discuss the important areas for ongoing industry-regulator communication.

Scientific Program Days –

Tuesday 4th March & Wednesday 5th March

 

Headlined with plenary sessions led by global ADC leaders showcasing and contextualising blockbusters and innovative ADC development. The main scientific program days will unveil cutting-edge, end-end ADC development insights through data-driven presentations from pioneering companies in the community across five content tracks:

  1. Discovery
  2. Preclinical & Translational
  3. Clinical Lessons
  4. Process & Analytical Development
  5. Manufacturing & Supply Chain

Throughout both days, you can access structured networking opportunities to reconnect with your peers and meet fresh faces to make new scientific and business “linkers” as the ADC community reunites all under one roof.

After the scientific presentations, make sure you don’t miss the popular Scientific Poster Session and Drinks Reception at the end of day one.

Workshop Day –

Thursday, 6th March

 

Reignited with the new insights from the main conference days, continue the conversation with like-minded peers in a series of discussions, debates, and forward-thinking sessions to find solutions to your most pressing challenges in the ADC field.
Taking place in more intimate settings, make sure to bring your own questions to these extended, collaborative sessions with content tailored for beginners in the field and for everyone working on ADCs.

Take of pick of your two favourite workshops including:

  • ADC Target Investigation: Keeping Up to Date With Cutting-Edge Anti-Tumour Target Discovery & Validation
  • Integrated ADC Development from Gene to IND & Beyond
  • Tackling Toxicity & the ADC Translational Mismatch: Optimising Model Selection & Non-Clinical Studies to Smoothen Translation to the Clinic
  • Pairing the Right Payload With the Right Target: What are the ADC Design Factors to Consider to Maximise ADC’s Therapeutic Index?
  • To Infinity & Beyond: Exploring the Cutting Edge of Novel ADC Payload & Novel Conjugate Development in Oncology & Beyond
FULL EVENT GUIDE
REGISTER
PARTNER WITH US